G. M. Shashidhar
ab,
P. Giridhar
c and
B. Manohar
*ab
aAcademy of Scientific and Innovative Research, New Delhi, India
bDepartment of Food Engineering, CSIR-Central Food Technological Research Institute, Mysore, India
cDepartment of Plant Cell Biotechnology, CSIR-Central Food Technological Research Institute, Mysore, India
First published on 19th January 2015
As a rich source of novel polysaccharides, Cordyceps sinensis (CS), one of the valued traditional Chinese medicinal fungi, is a major focus of many natural products research efforts. More than 33 polysaccharides have been characterized till the date. Polysaccharides from CS possess a wide spectrum of biological activities like antitumor, antioxidant, immunomodulatory activity, kidney and lung protection, etc. This review covers the recent literature and updates the information on polysaccharides from CS, covering about 130 research articles emphasizing the isolation, characterization of polysaccharides and their biological functions.
Cordyceps sinensis (CS) is a one of the valuable traditional medicinal fungi among Chinese medicines having long history. Over the millennia, CS has been treasured throughout Asia as one of the most effective natural tonics to strengthen vitality and promote longevity. Since CS possesses number of far reaching health effects, it is regarded as one of the cornerstone of traditional Chinese medicines for centuries.14 CS is basically entomophagous fungus, parasitizes larvae of ghost moths (Hepialus armoricanus) and produces a fruiting body assessed as an herbal remedy. It is mainly distributed in China, Tibetan Plateau, Bhutan, Nepal and northern part of India at an altitude of 3500–5000 metres above sea level. In Chinese, it is also called as Dong Chong Xia Cao which means “winter worm summer grass”15,16 and often known as a Himalayan Viagra. In Chinese Pharmacopeia, CS has been regarded as a celebrated drug since 1963, it is found to have similar medical effects of ginseng and deer velvet.17 CS contains major class of active ingredients like nucleosides, polysaccharides, sterols, etc. and products formulated from these have gained great popularity in Eastern medicines. In view of the above facts, there is an increased worldwide demand for CS which has led to overharvesting and subsequent meagreness of wild species. Hence researchers hunted for alternative approaches to produce CS artificially by bioreactor cultivating technology to meet human needs and to mitigate the pressure on natural resources of the species.
In previous review article,18 potent bioactive principles from CS, extraction methods, health benefits and other aspects have been discussed in detail. Since polysaccharides from CS are also believed to be major contributors to overall pharmacological effects, a systematic, informative review is felt necessary. This review will conceptually illustrate research activities carried out till date on submerged fermentation of CS for polysaccharides production and to promote CS as health foods, functional foods or nutraceuticals. The methods, technologies and instruments used to isolate, purify and elucidate polysaccharides structures are also covered.
Fig. 1 Significant impacts of various cultural conditions and additives on biomass and polysaccharides production. BM-biomass; PS-polysaccharides; EES-ether extract of Eupolyphaga sinensis. |
Few studies demonstrated the use of compounds other than sugars, nitrogen sources and minerals that have significant impact on biomass and polysaccharides production. Palmitic acid is basically a fatty acid and ether extract of Eupolyphaga sinensis have shown to act as stimulator of cell growth and extracellular polysaccharides of CS. Addition of above mentioned stimulators along with the modified basal media showed improved biomass and polysaccharides production by 1.5 fold.26 Liu and Wu (2012) investigated the effects of surfactant additives and medium pH on mycelia morphology and EPS production in liquid culture of a valuable medicinal fungus CS-HK1. Tween 80 (polysorbate 80) is one of the most favourable surfactants for EPS production by many microorganisms including medicinal fungi and found to enhance growth and metabolite production. The mechanism behind these effects is due to its surface active properties, lowering the mycelium liquid interfacial tension and thus the potential or tendency of mycelia to form aggregates. A decrease in the surface tension of the medium by a surfactant lowers the thermodynamic potential for the aggregation but favours the dispersion of mycelia.27 Selenium (Se) is an essential trace element of glutathione peroxidase (GSH-Px) that participates in synthesis of enzymes and protects the structure and function of biomembrane from over oxidation and damage. Researchers concluded that addition of Se to medium can potentially enhance the antioxidant activity of polysaccharides which in turn enhances adaptive immune responses.28 The study also revealed that the addition of citrus peel which is a source of pectin and flavonoids, along with culture broth containing different carbon sources, principally rice bran could enhance polysaccharides content and their anticomplementary, radical scavenging activities.29 Supplementing liquid medium with ammonium had stimulated the production of EPS in mycelial culture of CS. The ammonium feeding has increased the EPS production by 40% and also had a slightly positive effect at 5–10 mM L−1, but a negative effect at higher concentrations on the mycelium growth.30
Solid fermentation method of producing CS mycelia is not successfully followed because of constraints in recovering biomass free of contamination. Polysaccharides were extracted from CS mycelium grown on solid media containing soybean meal and rice bran (1:2 w/w) where the optimum inoculation amount, fermentation temperature, water content of medium, air relative humidity and fermentation time were found to be 20%, 26 °C, 60%, 60% and 7 days, respectively.31
However, the major drawbacks of hot water extraction are the high extraction temperature, long extraction time and low extraction efficiency. Various methods have been used to improve the extraction efficiency such as treatment with enzymes like cellulose,37 microwave,38 high pressure homogenization and high power ultrasound.39 Fig. 2 depicts steps involved and methods, techniques followed to extract, purify and characterize the polysaccharides from CS.
POLYS | Monomers compositional ratio | Main chain | Branch | MW (kDa) | Bioactivities | Reference |
---|---|---|---|---|---|---|
a POLY-polysaccharides; S-source of CS; C-cultured; N-natural; FCC-fruiting bodies of cultured CS; UNK-unknown. | ||||||
APSFC | Man:Glc:Gal = 3.5:1:1.5 | — | — | — | Immunomodulatory effects | 89 |
EPS-1AC | Glc:Man:Ga l = 15.2:3.6:1.0 | (1 → 6)-α-D-Glucose residues (∼77%) and (1 → 6)-α-D-mannose residues (∼23%) | (1-6)-α-D-Mannose residues and (1 → 6)-α-D-glucose residues at O-3 position of (1 → 6)-α-D-mannose residues of the backbone | 40 | — | 41 |
AEPSC | Glcp:GlcUp = 8:1 with a trace amount of mannose | (1 → 3)-linked α-D-Glcp | α-D-Glcp and α-D-Glc up, attached to the main chain by (1 → 6) glycosidic bonds at every 7th α-D-Glcp unit | 36 | Immunomodulatory effects | 7 |
PS-AC | Glc:D-Gal:D-Man = 2:1:1 | →3-α-D-Glcp-1 → 3-β-D-Glcp-1 → 3-β-D-Galp-1→ | Branch residue (α-D-Manp–1→) linked at the O-2 position of residue 3-α-D-Glcp-1 | 460 | Antihypercholesterolemia | 51 |
WIPSC | α-D-Glucose | (1 → 4)-linked α-D-Glcp | (1 → 6)-linked α-D-Glcp | 1180 | Antitumour & immunostimulating effects | 104 |
AIPSC | α-D-Glucose | (1 → 4)-linked α-D-Glcp | — | 1150 | Antitumour & immunostimulating effects | 104 |
CBHPC | Glc:Man:Gal = 95.19%:0.91%:0.61% | Glcp joined by 1 → 4 linkages and 1 → 3 linkages | The branching points are located at O-2 or O-6 of Glcp with α terminal-D-Glcp as side chain | — | Antifibrotic effect | 49 and 72 |
CS-PpC | Glc:Man:Gal = 21:2:1 | 1,3-β-D-Glucan | 1,6-branched chain | — | Monocyte activation | 90 |
CPS1C | Glu:Man:Gal:Ara = 46:36:18:1 | 1,6-Man | Glucose at C2, C3, C4 position | 99.1 | Kidney protection | 71 |
CPS2C | Glc:Man:Gal:GlcUA:Xyl:Ara:Rha = 30:25:14:4 : 3:3:1 | 1,6-Glc, 1,6-Man, 1,6-Gal | Different monosaccharide residues at C3 position | 25.6 | Kidney protection | 71 |
PCB IIC | Man:Gal:Glc = 1:0.51:0.50 | — | — | ∼60 | Immunoenhancing & tumorinhibiting effects | 128 |
PCB IC | Man:Gal = 1:0.73 | (1 → 4)-linked Manp | Galf and Manp | ∼60 | Immunoenhancing & tumorinhibiting effects | 128 |
PCA IC | Man:Gal = 1:1 | (1 → 4)-linked Manp | 1 → 2, 1 → 3, 1 → 6 linkages Galf and Manp | ∼556 | Immunoenhancing & tumorinhibiting effects | 128 |
PC IC | Man:Gal:Glc = 1:0.65:0.30 | — | — | ∼350 | Immunoenhancing & tumorinhibiting effects | 128 |
Glucomanno-galactanFCC | Glc:Man:Gal = 2.8:2.9:1 | Long backbone of (1 → 2), (1 → 4)-linked Man units and (1 → 3,6)-Glc units | (1 → 3)-linked Gal units and (1 → )-linked Glc units | 8.1 | Antioxidant activity | 44 |
CAPSC | Man:Gal:Glc | — | — | 2.7 | Kidney protection | 81 |
PolyhexNAcC | — | -4-β-D-ManNAc-(1 → 3)-β-D-GalNAc-(1→ | -Gal- at 3-position of ManNAc | 6 | Antioxidant activity | 128 |
UNKC & N | Glc and Gal | (1 → 4) linked-α-D-Glc units, (1 → 4) linked-β-D-Glc units and (1 → 4)-linked α-D-Gal units | — | — | — | 43 |
UNKN | Man:Glc:Gal = 1.00:16.61–3.82:1.60–1.28 | — | — | — | — | 50 |
CS-81002C | Man:Gal:Glc = 10.3:3.6:1 | →6-)-Man-(1→ | →3,6-)-Man-(1→side chains at C3 position→2,6-)-Man-(1→side chain at C2 position | 43 | Immunostimulating effect | 52 |
CHWpC | Man:D-Gal:D-Glc = 1.0:2.7:1.8 | — | — | ∼32 | Hypoglycaemic activity | 133 |
MannoglucanC | Man:Glc = 1:9 | (1 → 4)-and (1 → 3)-linked α-D-glucan | α-D-(1 → 6)-Manp | 7.7 | Anticancer effect | 130 |
PSC | Glc:D-Man:L-Ara:D-Gal = 8:90:1:1 | — | — | ∼83 | Immunomodulatory effect | 91 |
CordyglucansC | Glucose | (1 → 3)-linked backbone | (1 → 6)-linked branches | 12.86 | Antitumor activity | 105 |
D-GlucanC | Glucose | (1 → 3)-β-D-Glucosyl residues | (1 → 4)-β-linked D-glucosyl residue | 13.62 | Antitumor activity | 105 |
SCP-IC | Glucose | α-(1 → 4)-linked backbone | α-(1 → 6)-linkage | 184 | — | 54 |
CS-F10C | Gal:Glc:Man = 43:33:24 | (1 → 5 and/or 6)-linked β-D-Galf residues | (1 → 2)-linked α-D-Manp residues | 15 | Hypoglycemic activity | 111 |
CS-F30C | Gal:Glc:Man = 62:28:10 | — | — | 45 | Hypoglycemic activity | 109 and 110 |
CSP-1C | Glc:Man:Gal = 1:0.6:0.75 | — | — | ∼210 | Antioxidant activity; hypoglycemic activity | 48 |
PSCSN | — | — | — | 100 | Antitumor effect | 96 |
CT-4NN | Man:D-Gal = 3:5 | (1 → 6)-and (1 → 2)-linked α-D-Manp residues | (1 → 5)-linked β-D-galf residues, and (1 → 6)- linked α-D-galp residues | ∼23 | — | 131 |
CS-IN | Gal:D-Man = 1:1 | (1 → 2)-α linked-D-Manp residues | (1 → 3), (1 → 5), and (1 → 6)-linked-D-galf, (1 → 4)-linked D-galp residues | — | — | 36 |
EPSC | Man:Glu:Gal = 23:1:2.6 | — | — | 104 | Immunomodulatory & antitumour | 82 |
CordysinocanC | Glc:Man:Gal = 2.4:2:1 | — | — | 82 | Immunomodulatory activity | 83 |
HS002-IIC | — | Long backbone of (1 → 3)-linked α-D-ribofuranosyl units, (1 → 4)-linked α-D-xylopyranosyl units and (1 → 4)-linked β-D-glucopyranosyl units, substituted at C-6 position | β-D-Mannopyranosyl residues and β-D-galactopyranosyl residues terminated with α-L-arabinopyranosyl residues | 44 | Immunomodulatory activity | 88 |
CS-PSC | Man, Rha, Ara, Xyl, Glc, and Gal | — | — | 12 | Antioxidation activity & modulate immune function | 97 |
CME-1C | Man:Gal = 4:6 | Backbone of (1 → 4)-linked mannose | (1 → 6)-linked galactose residues attached to the O-6 of mannose | 27.6 | Cytoprotective effect | 127 |
Analysis of monosaccharide composition analysis involves cleavage of glycosidic linkages by acid hydrolysis, derivatization, detection and quantification by GC. In addition, high performance anion exchange chromatography with pulsed amperometric detection has been gradually developed to supplement traditional methods as it does not require derivatization of monosaccharide with high resolution. Fig. 3 shows the monosaccharide composition of different polysaccharides extracted from natural or cultured CS. Li et al. (2003) analysed CSP-1 for composition by capillary electrophoresis by using TFA and found that CSP-1 contained glucose, mannose and galactose in the ratio of 1:0.6:0.75.48 Monosaccharide composition of CBHP was determined by acid hydrolysing and analysed by high performance anion exchange chromatography with pulsed amperometric detection (HPAEC-PAD). The results revealed that CBHP consisted glucose, mannose and galactose (95.19%, 0.91% and 0.61%, respectively).49 Polysaccharides extracted by pressurized liquid method were analysed for their sugars composition by TFA hydrolysis, derivatization by treating hydroxylamine hydrochloridepyridine solution and GC-MS. The polysaccharides were found with mannose, glucose and galactose residues with a molar ratio of 1.00:16.61–3.82:1.60–1.28.50 A heteropolysaccharide, PS-A was subjected to activity guided fractionation and composition was analysed. PS-A composed of D-glucose, D-galactose, and D-mannose at a molar ratio of 2:1:1.51 Composition of CS-81002 was determined after acid hydrolysis by methylation analysis and results showed that it composed of mannose, galactose and glucose in the ratio of 10.3, 3.6 and 1.52
Fig. 3 Monosaccharide compositions (MC) of different extracted polysaccharides from natural or cultured Cordyceps sinensis. Data referred from Soltani et al. (2013).132 |
Molecular weight is one of the essential physical characters of a polymer and various techniques such as viscometry, osmometry, sedimentation, and HPLC have been used to determine the average polymer MW and polydispersity index. Also high performance gel permeation chromatography (HPGPC), and size exclusion chromatography with multi angle laser light scatter detection are an efficient methods for the evaluation of the absolute MW of polysaccharides which provides greater resolution than traditional gel permeation chromatography.53 Leung et al. (2009) characterized the EPS for their MW by using GPC, comparing against dextran MW standards. GPC spectrum showed five peaks correspond to molecules with MW range from about 5 kDa to more than 200 kDa.40 High performance size exclusion chromatography (HPSEC) analysis was also followed to determine MW of water soluble polysaccharides from CS.42 Combination of HPGPC and agarose gel electrophoresis techniques have been used to determine the MW of AEPS-1, an acidic polysaccharide fraction.45
Chemical structural features of polysaccharides can be derived by using techniques such as Periodate oxidation, Smith degradation, methylation analysis, enzymatic digestion, AFM, IR and NMR analyses. Miyazaki et al. (1977) derived the chemical structure of CS-1 by Periodate oxidation, Smith degradation, methylation analysis, partial hydrolysis and 13C-NMR spectrometry. The data showed CS-1 consists of mannan core and galactosyl oligomer as a branch chain. The mannan core mainly contains α-(1 → 2)-linked mannopyranosyl residues and branch chain consists of (1 → 3), (1 → 5) and (1 → 6) linked D-galactofuranosyl and (1 → 4)-D-galactopyranosyl residues.36 EPS-1A is a novel polysaccharide from CS characterised using FTIR and NMR techniques.41 Guan et al. (2011) compared and characterized polysaccharides from natural and cultured CS by enzymatic digestion method where cellulase, lichenase, β-(1,4)-D-galactanase, β-mannanase, α-amylase, and isoamylase have been selected for the study.19 Few studies have been reported in literature aimed at elucidating the polysaccharides structures from CS43,49,54 and has been listed in Table 2.
Polysaccharides | Structure | Method used | Bioactivity | Reference |
---|---|---|---|---|
a CS-correlation spectroscopy; NOS-nuclear overhauser spectroscopy; SD-Smith degradation; PO-Periodate oxidation, AFM-atomic force microscopy; AGE-agarose gel electrophoresis; HPGPC-high performance gel permeation chromatography; GF-gel filteration; DOSY-diffusion ordered spectroscopy. | ||||
CS-81002 | GF, methylation, GC | Immunostimulating effect | 52 | |
HS002-II | FTIR, HPGPC, AGE, AFM, NMR | Immunomodulatory activity | 88 | |
CBHP | Methylation analysis, 1D and 2D NMR spectroscopy | Antifibrotic effect | 47 and 72 | |
SCP-I | Methylation, SD degradation, acetolysis, NMR | — | 54 | |
EPS-1A | GC, GC-MS, FTIR, 1H NMR and 13C NMR, acid hydrolysis, methylation, PO and SD | — | 104 | |
PolyhexNAc | MS, methylation and NMR | Antioxidant activity | 129 | |
Mannoglucan | FTIR and NMR | Anticancer effect | 130 | |
PS-A | 1H, 13C NMR, CS, and NOS | Anti-hypercholesterolemia | 51 | |
CME-1 | GF, GC-MS and NMR (DOSY) | Cytoprotective effect | 123 |
Peng et al. (2013) investigated the antiliver injury effect of polysaccharides against carbon tetra chloride (CCl4) where colchicine was used as a positive control. They observed the effects on hepatic stellate cell (HSC) activation, transforming growth factor-β1 (TGF-β1)/Smad pathway, as well as matrix metalloproteinase MMP2, MMP9 and tissue inhibitor of metalloproteinase TIMP1, TIMP2 and inhibition of liver injury and fibrosis was confirmed by drop in serum alanine aminotransferase, aspartate aminotransferase, total bilirubin, hepatic hydroxyproline and rise in serum albumin, as well as alleviation of histological changes.62 In a similar study pharmacological effect of Cordyceps polysaccharide on dimethylnitrosamine (DMN) induced liver fibrosis in rats was investigated63 and the treatment of polysaccharides showed significant reduction of protein expression of proliferating cell nuclear antigen (PCNA) in liver tissues.64 Cordyceps polysaccharides had also a significant suppression effect on hepatic stellate cells of rat, and the activity of nuclear factor κB, and down regulated the expression of cytokine tumor necrosis factor in a dose dependent manner. It also reduced the proliferation of hepatic stellate cells by inhibiting the activity of NF-κB and the expression of TNF-α and also lowering the level of protein.65
Fang et al. (2000) discovered the mechanism behind the action of polysaccharides on liver fibrosis induced by immunologic injury in rats. Results concluded that Cordyceps polysaccharides attenuate liver fibrosis, decrease hepatic Hyp content and collagen production, reduce transforming growth factor β1 and its receptor expression and decrease cell Dm expression.66
In ureteric obstruction (UUO) model of renal fibrosis and tubular epithelial cell line HK-2, histological and immunohistochemical assessment of renal injury was made at day 7 and treated with characterized fraction of polysaccharide (Cp-F1) of CS.72 The significant attenuation of UUO was noticed, evidencing the antagonist activity by CS, mediated via large soluble polysaccharide aggregate, preventing induction of fibronectin and α-SMA, and inhibition of the epithelial cell marker E-cadherin. Furthermore Cp-F1 inhibits TGF-β1 dependent activation of a Smad signalling and suppresses the expression of TGF-β receptor mRNA and protein.72 In the similar studies, acute kidney injury in rat was induced by denaturation haemoglobin and treatment with Cordyceps polysaccharides showed significant palliation in injury of renal function (P 0.01) and renal pathologic changes (P 0.01) concluding its possible mechanism maybe related to improve renal function, rectify abnormal metabolism, promote renal tubular restoring and regeneration.73 The therapeutic effects of Cordyceps polysaccharide on occluding renal artery induced acute kidney injury in dog and on adenine induced chronic renal failure (CRF) in rats. Renal function, biochemical indicators, kidney index, renal pathologic changes were observed after treatment confirming the protective effect of polysaccharides on kidney and kidney improvement.74,75
An investigation discovers therapeutic effect of Cordyceps polysaccharides on the kidneys frozen chronic renal failure in rats is available. The study was conducted on rats divided into six groups among which three groups were treated with high, medium and low dose of polysaccharides 160, 80 and 40 mg kg−1, respectively. After administration biochemical indices of blood of the rats, serum total superoxide dismutase and malondialdehyde (MDA) levels were detected as well as changes in renal pathology. Results concluded that Cordyceps polysaccharides can be effective in preventing the occurrence of chronic renal failure and development, improve renal function, correct metabolic disorders, and promote the repair and regeneration of renal units.76 Chen et al. (2009) established CRF rat model by 5/6 nephrectomy to study the therapeutic effects of polysaccharides and biochemical indicator, renal function, and renal pathologic changes were observed confirming the renal function improvement.77 Few studies brief the protective effects of polysaccharides on renal injury.78–81
Exopolysaccharides (EPS) from CS were found to possess both immunomodulatory and antitumor effects by activating the immunocytes and promote cytokines expressions. Splenocytes were treated with EPS having molecular weight about 1.04 × 105 at different doses and different treatment timings. EPS elevated proliferation ability of spleen lymphocytes only at 100 μg mL−1 after 48 h treatment and tumor necrosis factor alpha (TNF-α), interferon-α (IFN-γ), and interleukin-2 (IL-2) mRNA levels in splenocytes and thymocytes were increased after EPS treatment for 2, 4, 8, or 20 h. EPS also significantly elevated splenic TNF-α and IFN-γ protein expressions at 100 μg mL−1 and increased thymic TNF-α and IFN-γ protein levels at 50 and 100 μg mL−1.82 Cheung et al. (2009) have successfully isolated the novel EPS, namely Cordysinocan with the molecular weight ∼82 kDa which induce cell proliferation and the secretion of interleukin-2, interleukin-6 and interleukin-8. In addition, the phosphorylation of extracellular signal-regulated kinases (ERK) was induced transiently by the treatment of cordysinocan. Moreover, application of cordysinocan in cultured macrophages increased the phagocytosis activity and the enzymatic activity of acid phosphatase, confirming the triggering potential of immune responses.83 The immunomodulating effects of polysaccharides from cultured CS (PCCS) have been evaluated on non-specific and specific immunologic function of immunosuppressed mice. The treatment of PCCS has increased the K and α indices in carbon clearance test, enhanced the phagocytosis function of mononuclear macrophage, murine ear swelling and elevated the hemolysin level in immunosuppressed mice, suggesting that polysaccharides could improve the cellular and humoral immunologic function in immunosuppressed mice.84,85 Administration of CS polysaccharides to LACA mice for 15 days at the dose of 6.85 mg kg−1 not only enhanced delayed type hypersensitivity response but also promoted the plaque forming cell (PFC) response and hemagglutination titers against sheep red cell (SRBC) indicating CS polysaccharides could enhance immune response in mice.86 The polysaccharide treatment caused increase in the weight of thymus gland and improved the delayed hypersensitivity induced by DNFB and also enhanced the phagocytic ability of monocyte macrophages.87
He et al. (2013) isolated a novel protein bound polysaccharide, namely HS002-II, from Hirsutella sinensis with 44 kDa molecular weight and found to enhance the secretion and expression of the cytokines iNOS, TNF-α, IL-1β and NF-κB by HS002-II, which could be developed as a potential immunomodulatory source. The graphical representation shows the IκB-NF-κB pathway behind the immunomodulatory effect of HS002-II in Fig. 4.88 Similar effects were observed with the acid polysaccharide fraction (APSF) treatment on murine macrophage cell line RAW264.7.89 Novel acidic polysaccharides AEPS-1, fractionated from the EPS produced by CS-HK1 fungus in mycelial culture, were treated on Raw264.7 macrophage cell cultures to evaluate the immunomodulatory effect at suitable doses between 25 and 250 g mL−1. The results suggest that the treatment significantly stimulated the release of four major cytokines, TNF-α, IL-1β, IL-6 and IL-10 indicating strong immunostimulatory activity of AEPS-1.7 Polysaccharides from CS play major role in inducing monocyte activation. Among active components crude (CS-P), soluble (CS-Ps) and insoluble (CS-Pp), the macrophage production of TNF-α by CS-Pp was to the highest extent.90 The polysaccharide namely, CS-81002 was found to exhibit immunostimulatory effect on phagocytic function of macrophages in normal mice at dosages of 5 mg kg−1.52 A study demonstrated the potential effect of various extracts of CS mycelium like, petroleum ether extract (PE), ethyl acetate extract (EAE), ethanol extract (EE), glycoprotein (GP) and a purified polysaccharide (PS) on cellular and humoral immune responses of ICR mice against ovalbumin (OVA). The immunized ICR mice were treated with polysaccharides having molecular wt ∼83 kDa at 3 dose levels enhanced the OVA specific IgG, IgG1 and IgG2b antibody in serum to significant levels, concluding these polysaccharides can potentially acts as safe adjuvants.91
Fig. 4 Immuno-stimulation induced via IκB-NF-κB signalling pathway by HS002-II from CS. A study demonstrates the HS002-II polysaccharide treatment of RAW264.7 cells, caused the activation of NF-κB happened via phosphorylation of serine residues and degradation of IκB by IKK. The active NF-κB was translocated into nucleus and modulates gene expressions. NF-κB-nuclear factor kappa-light-chain-enhancer of activated B cells; IKK-IκB kinase; iNOS-inducible nitric oxide synthase; TNF-tumor necrosis factor; IL-interleukin. Adopted from He et al. (2013).88 |
Exopolysaccharides fraction (EPSF) from CS mycelium posed activity on B16 melanoma bearing mice and proved to be a potential adjuvant in cancer therapy. The mice were administered with EPSF peritoneally at 3 different doses for 14 times, c-Myc, c-Fos, and VEGF levels in the lungs and livers were found to be significantly lower than those of untreated mice.92 Similar study demonstrated the effect of EPSF on immunocytes of H22 tumor bearing mice where mice were treated by intraperitoneal injection at doses of 15 mg kg−1 (low dose), 30 mg kg−1 (mid dose) and 60 mg kg−1 (high dose). It was observed that EPSF not only significantly inhibited the H22 tumor growth, but also significantly elevated immunocytes activity. It significantly enhanced the phagocytosis capacity of peritoneal macrophages and proliferation ability of spleen lymphocytes at all the three doses; it significantly promoted macrophages TNF-α expression and spleen lymphocytes cytotoxicity. EPSF also significantly elevated TNF-α and IFN-γ mRNA expression of splenic lymphocytes.93 Similar dual effects were observed by others also.94 The effect of EPS from submerged cultured CS on immunomodulatory enhancement of cytokine synthesis, CD11b expression, and phagocytosis was well explained in a study. This immunomodulatory study explored the effect of polysaccharides (Fr. A & Fr. B) on cytokines release, CD11b expression, and phagocytosis in monocytes, PMN, leukocytes. The study concluded that EPS induced the production of tumor necrosis factor alpha (TNF-α), interleukin IL-6, and IL-10 dose dependently. Moreover EPS could significantly augment surface expression of CD11b and has induced phagocytosis in monocytes and polymorphonuclear neutrophils (PMN).95 The graphical representation of immunomodulatory study is depicted in Fig. 5.
Fig. 5 Polysaccharides induced cytokine production, CR3 expression, and phagocytosis. Adopted from Kuo et al. (2007), Sheng et al. (2011), Akaki et al. (2009).82,90,95 |
In an in vitro culture system leukemic U937 cells were treated with polysaccharides fraction from CS (PSCS). The study revealed that the conditioned medium with PSCS (10 μg mL−1) stimulated the blood mononuclear cells (PSCS-MNC-CM), significantly inhibiting the proliferation of U937 cells with growth inhibition rate of 78–83%. The treatment of PSCS induced about 50% of the cells differentiating into mature monocytes/macrophages expressing nonspecific esterase (NSE) activity and the surface antigens of CD11b, CD14, and CD68. The levels of interferon (IFN)-γ, tumor necrosis factor (TNF)-α, and interleukin (IL)-1 were greatly increased with PSCS stimulation concluding especially IFN-γ and TNF-α acted synergistically on inhibiting cell growth and inducing differentiation of the target U937 cells.96
Heteropolysaccharide from the fruiting bodies of cultured CS (CS-PS) having average molecular weight of 12 kDa were investigated for their effect on immune function of BALB/c mice exposed to 60Co gamma radiation. Mice were administered CS-PS with doses of 50, 100 or 200 mg kg−1 body weight, then exposed to 60Co for four days. The treatment showed significant enhancement in lymphocyte proliferation, the activity of macrophage phagocytosis, DTH and total SOD enzyme activity compared to control group. And also significant reduction in lipid peroxidation level and levels of cytokine IL-4, IL-5 and IL-17 were found to be affected as compared to control group.97 Song et al. (2011) evaluated the effect of EPS from one of the anamorph of CS on murine dendritic cells (DCs). In this experimental study murine DCs were derived from the bone marrow of C57BL/6 mice which are treated with EPS. During the study phenotype molecules, level of phosphorylated signal transducers and activators of transcription 3 (p-STAT3) of DCs were evaluated. The results showed that EPS promoted the levels of surface molecules MHC II, CD40, CD80 and CD86 of DCs and decreased their ingestion ability. The mRNA expressions of cytokines (IL-12p40 and TNF-α) and inducible nitric oxide synthase were up regulated by EPS. It was also found that EPS significantly down regulated p-STAT3 level of DCs. The results concluded that the promotion of DC's maturation and activation by EPS is probably related to the inhibition of STAT3 phosphorylation.98 Potential application of polysaccharide fraction of CS (PSCS) on rapid generation of activated DCs that can be utilized as vaccine for treating chronic myeloid leukaemia (CML). PSCS can increase T cell immunoresponse when CML-DCs incubated by PSCS caused the rapid generation of the co-stimulatory molecules, CD86 and HLA-DR, and the enhancement of IL-12 expression and stimulatory capacity in allogeneic mixed lymphocyte reaction (MLR).99
Polysaccharides from CS were observed to have immune enhanced function in adjuvant arthritis (AA) rats in vitro. Immune cells were treated with CP in order to detect the change of ConA induced splenocyte proliferation, IL-1 and IL-2 synthesis wherein CP (10–100 mg L−1) could not only enhance the reduced ConA-induced splenocyte proliferation, but also improve the decreased IL-2 synthesis in AA rats.100 Furthermore, crude polysaccharides from wild type and mycelia of CS were also observed to induce macrophage from mouse abdominal cavity to produce the tumor necrosis factor (TNF-α).101
Combination treatment of the polysaccharide rich fraction of CS and cisplatin was tested on H157 NSCLC cells with aim to investigate adjuvant role of CS in the treatment of non-small cell lung cancer (NSCLC). The expression levels of VEGF and bFGF protein were significantly reduced in the cells treated with a combination of CS and cisplatin, concluding CS may be a potential adjuvant chemotherapeutic agent in NSCLC therapy.107 Shen et al. (2009) studied the effects of polysaccharide from CS (PSCS) on triptolide (TPL) induced apoptosis in the HL-60 cells. MTT assays showed that different concentrations of PSCS inhibited the cell viability. Flow cytometry indicated that TPL markedly increased the apoptosis rate of the HL-60 cells, and PSCS enhanced the apoptosis in a dose dependent relationship. Western blot showed that TPL did not inhibit the expression of the Caspase-3, 6, 7, 9 and NF-κB proteins, and when cells were treated with PSCS, the expression of proteins decreased as the PSCS concentration increased. So PSCS can enhance TPL induced apoptosis in HL-60 cells and inhibit the expression of NF-κB and Caspase 3, 6, 7, 9, which might be a possible signalling pathway of inducing apoptosis.108
Purified polysaccharides named as a CSP-1 found to show hypoglycemic activity with antioxidation effect in normal, alloxan diabetic mice and streptozotocin (STZ) diabetic rats. Oral administration of CSP-1 at 200 and 400 mg kg−1 body wt per day for 7 days significantly reduced the blood glucose level by 12.07 ± 3.2% and 22.57 ± 4.7% in normal mice, respectively. In case of both STZ induced diabetic rats and alloxan induced diabetic mice at a dose higher than 200 mg kg−1 body wt daily for 7 days caused significant drop in blood glucose level. The study concluded that CSP-1 has increased insulin level in diabetic animals, which suggests that CSP-1 may stimulate pancreatic release of insulin and/or reduce insulin metabolism.112 Similar studies have been reported the hypoglycemic effect of purified fraction of polysaccharides.113,114 Huang et al. (2002), proposed the mechanism behind the hypoglycemic activity induced by polysaccharides (PCS) from CS mycelium. PCS has raised the glucose uptake in insulin resistant adipocytes.115
Li et al. (2003) isolated polysaccharides (CSP-1) by using antioxidation activity guided fractionation which have reported to exhibit strong protective effect against hydrogen peroxide (H2O2) induced insult in the cultured rat pheochromocytoma PC12 cells. The treatment of H2O2 at 200 μM reduced the activities of antioxidant enzymes GSH-Px and SOD by 86% and 81%, respectively and pre-treatment with CSP-1 attenuated the changes of GSH-Px and SOD activities in a dose dependent manner. At 100 μg mL−1 of CSP-1, the H2O2 decreased GSH-Px and SOD activities were revered by over 50% and malondialdehyde production also reduced. The study concluded that polysaccharides from CS can provide protection against the free radical induced neuronal cell toxicity.48 Shen et al. (2011) carried out the study where the pheochromocytoma PC12 cells were treated with H2O2 at 300 μM to induce oxidative stress. The oxidative stress was reduced by polysaccharides (APS) treatment which was manifested through changes in activities of GSH-Px, CAT, and SOD, inhibition of ROS accumulation at 100 and 200 μg mL−1 of APS for 24 h, inhibition of intracellular Ca2+ concentration to 133% and 125% and APS significantly inhibited overproduction of MDA.116 Similar studies are also been reported to demonstrate antioxidative activity in literature.28
Four fractions of ethanol extracts of CS, which was fractionated using supercritical CO2 as the elution solvent were characterized to be a polysaccharides and cordycepin showed strong scavenging ability of free radicals. The four fractions at 2 mg mL−1 showed free radical scavenging potency, 93%, 75%, 66%, 47%, and 27%, respectively.117 Dong and Yao (2008) investigated and evaluated the antioxidant potency of polysaccharides isolated from water extract of CS using six in vitro assays. Among these assays, the extracts showed the best effect on the inhibition of linoleic peroxidation with the lowest IC50 values and with an inhibition rate over 90% at concentration of 0.8–1.6 mg mL−1, which proved to be more stable than that of α-tocopherol, a recognized natural antioxidant. The findings demonstrated that superoxide anion and hydroxyl radicals scavenging activities were less than BHT, DPPH assay showed 80% inhibition, finally moderate reducing power and ferrous ion chelating activity.118 Antioxidant potential was evaluated by using xanthine oxidase assay, the induction of haemolysis assay and the lipid peroxidation assay. The study concluded that partial purification of crude polysaccharides enhances the activity by 10 to 30 folds.119
Crude EPS isolated from CS mycelium, are basically polysaccharide protein complexes and were studied for their ability to scavenge radicals and ferric reducing ability of plasma. The results showed that EPS have moderate effect, concluding these biopolymers from the CS mycelial fermentation provide a source of natural antioxidants with potential value for health foods and therapeutics.40 Hydrolysed EPS fractions reported to exhibit high (30–80%) antioxidant and radical scavenging activities.120,121 Polysaccharides (PS) isolated from CS studied for their antioxidative activity against H22 bearing mice, showed that the PS treatment for 9 days had significantly inhibited H22 tumor growth, enhanced SOD activity of liver, brain and serum as well as GSH-Px activity of liver and brain in tumor bearing mice. PS also significantly reduced the level of MDA in liver and brain of tumor bearing mice.24 Heteropolysaccharides from fruiting bodies of cultured CS have effectively reduced oxidative injury to BALB/c mice upon exposure to 60Co. The total SOD enzyme activity in the CS-PS groups was significantly enhanced and lipid peroxidation level was significantly reduced.97 The glucomannogalactan (CPS1), a water soluble polysaccharide has been evaluated for its antioxidant activity by using assays like; hydroxyl radicals scavenging, the reducing power, Fe2+ chelating activity, scavenging effect on superoxide radicals, as well as the inhibition of hydrogen peroxide induced haemolysis. The results concluded that CPS1 showed a high antioxidant effect, especially scavenging effect of hydroxyl radicals, the reducing power and Fe2+ chelating activity.44
Li and Li (2013) studied the enzymatic method of extracting water soluble polysaccharides and evaluation for their antioxidative activity. Water soluble polysaccharides have been extracted by incubating water with 7.5 U or 375 U of cellulase at 50 °C for 2 h. The soluble polysaccharide yield increased 30.38% to 33.23% to 38.10%, while DPPH free radicals scavenging and reducing power were found to be higher than those of untreated control.37 Huang et al. (2013) isolated five EPS fractions P1/5, P2/5, P1, P2 and P5 from the fermentation medium of a medicinal fungus CS by gradient precipitation with ethanol at 1/5, 2/5, 1, 2, and 5 volume ratios to the liquid medium. Each fraction was tested for its antioxidant activity among which P1/5 and P2/5 showed poor response, P1 and P2 showed low to moderate and P5 showed very strong activity.122
Cordyceps pretreatment has significantly lowered DNA damage in UVB irradiated human fibroblast cells (P < 0.01) after 30 min and 24 h. There was a 27% reduction in cyclobutanepyrimidine dimers (CPDs) in irradiated cells with 24 h pretreatment with 200 mg mL−1 of the hot water extract, and a 34% reduction with 24 h pretreatment with 200 mg mL−1 of the exopolysaccharide extract. Clear evidence of protection against UVB induced CPDs was seen with Cordyceps mycelial extracts. CS may thus offer photoprotection and lower the risk of basal cell carcinoma, the main skin cancer caused by CPDs.127
This journal is © The Royal Society of Chemistry 2015 |